MarketCapExport financials
Akers Biosciences, Inc. (AKER)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
TelegramAkers Biosciences, Inc. Financial Statements 2020-2011 | AKER
Annual Financial Statements Akers Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
809 K | 888 K | 6.36 M | 1.2 M | 3.26 M | 3.08 M | 8 M | 4.14 M | - | - |
Shares |
306 K | 306 K | 229 K | 24.7 K | 14.1 K | 13.4 K | 12.4 K | 4.16 K | - | - |
Net Income |
-17.6 M | -3.89 M | -10.8 M | -5.81 M | -3.3 M | -9.31 M | -3.13 M | -1.53 M | -2.45 M | -3.58 M |
Revenue |
- | 1.58 M | 1.67 M | 3.93 M | 2.96 M | 2.12 M | 4.43 M | 3.58 M | 1.52 M | 1.79 M |
EBITDA |
-12.3 M | -3.76 M | -8.38 M | -4.88 M | -4.46 M | -6.82 M | -2.95 M | -1.55 M | -2.19 M | -3.33 M |
Operating Expenses |
7.99 M | 4.28 M | 8.68 M | 7.56 M | 6.51 M | 8.22 M | 6.46 M | 3.47 M | 3.17 M | 4.74 M |
General and Administrative Expenses |
- | 3.73 M | 5.67 M | 4.08 M | 3.01 M | 4.03 M | 3.98 M | 1.52 M | 1.49 M | 3.28 M |
Annual performance
Select metrics to display
All numbers in USD currency
Main types of financial statements Akers Biosciences, Inc. AKERFinancial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.
- Income Statement
Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability. - Balance Sheet
Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
Liabilities — debts and other external sources of financing.
Equity — owners' capital and retained earnings. - Cash Flow Statement
Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
- IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
- GAAP — Generally Accepted Accounting Principles used in the United States.
- RAS — Russian Accounting Standards, used domestically in Russia.
Financial reporting Akers Biosciences, Inc. plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.
In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.
Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.
Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.
Financial statements of other stocks in the Medical instruments industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M |  USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | USA |
 |
Masimo Corporation
MASI
|
- | - | $ 9.59 B | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
$ 38.61 | 3.51 % | $ 1.84 B | USA |
 |
electroCore
ECOR
|
$ 7.41 | 0.82 % | $ 62.9 K | USA |
 |
Haemonetics Corporation
HAE
|
$ 116.16 | -0.81 % | $ 5.48 B | USA |
 |
Alcon
ALC
|
$ 70.63 | 4.75 % | $ 34.8 B |  Schweiz |
 |
InfuSystem Holdings
INFU
|
$ 14.14 | 0.64 % | $ 292 M | USA |
 |
Intuitive Surgical
ISRG
|
$ 443.85 | 3.67 % | $ 158 B | USA |
 |
Repro Med Systems
KRMD
|
$ 3.08 | -1.13 % | $ 142 M | USA |
 |
AtriCure
ATRC
|
$ 59.3 | 2.83 % | $ 2.83 B | USA |
 |
Milestone Scientific
MLSS
|
$ 0.31 | 0.48 % | $ 25.4 M | USA |
 |
Merit Medical Systems
MMSI
|
$ 93.94 | 2.78 % | $ 5.56 B | USA |
 |
Nephros
NEPH
|
$ 3.52 | -1.95 % | $ 37.4 M | USA |
 |
Envista Holdings Corporation
NVST
|
$ 23.97 | 3.36 % | $ 4.03 B | USA |
 |
Pro-Dex
PDEX
|
$ 62.38 | 3.01 % | $ 201 B | USA |
 |
Pulse Biosciences
PLSE
|
$ 52.68 | 2.67 % | $ 3.55 B | USA |
 |
Repligen Corporation
RGEN
|
$ 178.71 | -0.72 % | $ 10 M | USA |
 |
ResMed
RMD
|
$ 253.06 | 2.67 % | $ 36.8 B | USA |
 |
STAAR Surgical Company
STAA
|
$ 22.49 | 4.07 % | $ 1.11 B | USA |
 |
STERIS plc
STE
|
$ 232.22 | 4.85 % | $ 22.8 B | USA |
 |
Teleflex Incorporated
TFX
|
$ 136.58 | 4.74 % | $ 6.09 B | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | USA |
 |
Utah Medical Products
UTMD
|
$ 75.06 | 0.46 % | $ 243 M | USA |
 |
Baxter International
BAX
|
$ 25.65 | 3.85 % | $ 13.2 B | USA |
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M | USA |
 |
Becton, Dickinson and Company
BDX
|
$ 200.42 | 3.13 % | $ 57.7 B | USA |
 |
West Pharmaceutical Services
WST
|
$ 394.03 | 0.14 % | $ 28.5 B | USA |
 |
AngioDynamics
ANGO
|
$ 12.02 | 1.09 % | $ 499 M | USA |
 |
Glaukos Corporation
GKOS
|
$ 176.69 | -0.09 % | $ 10.1 B | USA |
 |
iRhythm Technologies
IRTC
|
$ 119.64 | 5.36 % | $ 3.83 B | USA |
 |
Harvard Bioscience
HBIO
|
$ 8.34 | -1.77 % | $ 370 M | USA |
 |
LeMaitre Vascular
LMAT
|
$ 85.33 | 1.98 % | $ 1.93 B | USA |
 |
ICU Medical
ICUI
|
$ 168.33 | 4.66 % | $ 4.15 B | USA |
 |
OraSure Technologies
OSUR
|
$ 3.8 | -1.55 % | $ 279 M | USA |
 |
Retractable Technologies
RVP
|
$ 0.58 | 0.03 % | $ 17.4 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 9.5 | 4.63 % | $ 1.89 B | USA |
 |
Stereotaxis
STXS
|
$ 1.0 | 1.83 % | $ 91 M | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | USA |
 |
The Cooper Companies
COO
|
$ 61.65 | 4.54 % | $ 12.3 B | USA |
 |
Microbot Medical
MBOT
|
$ 0.94 | 0.19 % | $ 43 M |  Israel |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | USA |